Observable data points shared across all narratives
Chinese authorities have formally charged Leon Wang, the former regional head at AstraZeneca, roughly a year after detaining him, according to multiple reports. The case places renewed focus on China’s enforcement posture toward multinational pharmaceutical firms and their local executives, with potential implications for compliance practices, operational risk, and executive exposure in the sector.